ARCHIVES

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

This article is from The Cancer Letter archive.

Vol. 19 No. 02 | January 8, 1993

Download PDF Visit The Full Archive

Related Articles

Concepts For Education Initiatives In Breast Ca Approved As RFA

July 9, 1993

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

July 11, 2014

Women’s Health Initiative Trial Produced $37.1 Billion in Returns

May 9, 2014

In Brief: Board Subcommittee Meetings On Comprehensive Centers Postponed; FDA Committee Uncharted

March 10, 1978

Core Grants Limit Formula Must Wait On Profiles

January 27, 1978

Steven Woolf: Why CMS Should Not Cover LDCT

May 9, 2014